| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,174 |
4,696 |
$217K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,837 |
1,657 |
$121K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,811 |
1,624 |
$28K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
473 |
428 |
$20K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
568 |
541 |
$13K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
381 |
333 |
$12K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
134 |
125 |
$4K |
| 81002 |
|
1,084 |
1,012 |
$3K |
| 81025 |
|
764 |
710 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
55 |
41 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
72 |
64 |
$1K |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
14 |
12 |
$1.65 |